Altimmune to Announce 12-Week Data From ALT-801 Phase 1 Trial on September 28, 2021

Monday, September 27, 2021 1 min read

Key Takeaway: Altimmune to Announce 12-Week Data From ALT-801 Phase 1 Trial on September 28, 2021

Full Press Release Details

Altimmune to Announce 12-Week Data From ALT-801 Phase 1 Trial on September 28, 2021.